Adding a short-term regimen of C1-INH concentrate to the preventive treatment of a 63-year-old man with hereditary angioedema (HAE)…
Articles by Patricia Inácio, PhD
A single subcutaneous or under-the-skin injection of STAR-0215 — an experimental treatment that aims to prevent swelling attacks in…
Treatment with rituximab — approved for certain cancers to reduce the levels of antibody-producing immune cells — is effective to…
Women with hereditary angioedema (HAE) see an increase in the number and severity of disease attacks during pregnancy and while…
Pharvaris has completed patient enrollment for its proof-of-concept CHAPTER-1 clinical trial that will evaluate the safety and effectiveness of…
Enrollment for the Phase 2 portion of a clinical trial testing NTLA-2002, Intellia Therapeutics’ experimental gene-editing therapy for…
A 26-year-old woman developed a rare case of non-episodic angioedema associated with eosinophilia (NEAE) following her second dose of the…
The use of Dupixent (dupilumab), an approved treatment for skin and respiratory conditions linked to a specific type of…
Healthcare costs continuously dropped for people with hereditary angioedema (HAE) who were on long-term preventive treatment with Takhzyro…
Firazyr (icatibant injection) rapidly eased acute attack symptoms in two Japanese children with hereditary angioedema (HAE), according to…